5195 — Bando Chemical Industries Balance Sheet
0.000.00%
IndustrialsBalancedMid CapSuper Stock
- ¥71bn
- ¥64bn
- ¥104bn
- 89
- 76
- 75
- 96
Annual balance sheet for Bando Chemical Industries, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 18,001 | 15,127 | 19,298 | 19,571 | 17,958 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 21,858 | 20,206 | 20,638 | 22,740 | 23,092 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 53,564 | 48,822 | 53,660 | 59,200 | 60,470 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 32,597 | 33,913 | 32,880 | 32,954 | 32,521 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 102,557 | 110,297 | 116,282 | 116,381 | 118,971 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 24,232 | 25,829 | 27,658 | 28,520 | 32,169 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 34,686 | 46,649 | 45,790 | 44,247 | 41,314 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 67,871 | 63,648 | 70,492 | 72,134 | 77,657 |
Total Liabilities & Shareholders' Equity | 102,557 | 110,297 | 116,282 | 116,381 | 118,971 |
Total Common Shares Outstanding |